CompoundingGain

First Oral approved favipiravir medication for COVID

Long
NSE:GLENMARK   GLENMARK PHARM


Sitting just under resistance at 421 expect this to be taken out on open and the retest IF it happens is a good spot to load up.

Recon this should fly to 574 then get knocked back a bit for a while before flying up with more power .

Might be wrong and the FOMO on this may keep blasting it up , the downtrend line is not that far off so all indicators should turn into buy once that is taken out .

Lets see ..

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.